MedTrace Logo

Trial of Nano-hydroxyapatite-Containing Toothpastes for Relief of Dentin Hypersensitivity

NCT04590040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 192

Last updated 2023-08-16

Study results available
· View outcomes & findings →

Summary

Subjects will be enrolled into 3 balanced groups each using a different strength toothpaste. Dental hypersensitivity (DHS) will be assessed at study start, midway and study end.

Conditions

  • Dentin Sensitivity

Interventions

OTHER

Placebo

0% nano-HAP toothpaste

DEVICE

15% nano-HAP toothpaste

Toothpaste with identical base formulation as the placebo containing 15% nano-HAP

DEVICE

5% KNO3 toothpaste

Toothpaste with identical base formulation as the placebo containing 5% KNO3

Sponsors & Collaborators

  • Sangi Co., Ltd.

    collaborator INDUSTRY

  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Bennett T Amaechi, BDS, MS, PhD · University of Texas Health at San Antonio

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-28
Primary Completion
2022-02-05
Completion
2023-03-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04590040 on ClinicalTrials.gov